Lyell Immunopharma
Developing next-generation T-cell therapies for patients with solid tumors.
biotech
Company facts
- Founded
- 2018
- Employees
- 300
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: LYEL
Open positions
1 job
2 views last week
Associate Director, Medical Affairs Operations
Open 93d North AmericaContract
United States
Oversee Medical Affairs operations for a biotech firm developing next-gen CAR T-cell therapies, building systems, budgets, and AI-enabled workflows to support clinical launches and compliance.
AI Ai Enablement Analytics Automation Backbone.js +3 skills
230K – 280K $